A Study to Evaluate the Clinical Efficacy and Safety of Subcutaneously Administered C1-esterase Inhibitor in the Prevention of Hereditary Angioedema
Clinical trial NCT01912456 · COMPLETED
Trial details
- NCT number
- NCT01912456
- Sponsor
- CSL Behring
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-01-01
- Primary completion
- 2015-10-01
- Enrollment
- 90
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.